Neuronetics Net Income vs. Profit Margin
| STIM Stock | USD 2.20 0.21 10.55% |
Net Loss | First Reported 2016-03-31 | Previous Quarter -10.1 M | Current Value -9 M | Quarterly Volatility 3.4 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.84 | 0.83 |
|
|
For Neuronetics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Neuronetics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Neuronetics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Neuronetics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Neuronetics over time as well as its relative position and ranking within its peers.
Neuronetics | Build AI portfolio with Neuronetics Stock |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neuronetics Profit Margin vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Neuronetics's current stock value. Our valuation model uses many indicators to compare Neuronetics value to that of its competitors to determine the firm's financial worth. Neuronetics is currently regarded as top stock in net income category among its peers. It also is currently regarded as top stock in profit margin category among its peers . Neuronetics reported last year Net Loss of (39.34 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Neuronetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Neuronetics Profit Margin vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Neuronetics |
| = | (43.73 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Neuronetics |
| = | (0.34) % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Neuronetics Profit Margin Comparison
Neuronetics is currently under evaluation in profit margin category among its peers.
Neuronetics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Neuronetics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Neuronetics will eventually generate negative long term returns. The profitability progress is the general direction of Neuronetics' change in net profit over the period of time. It can combine multiple indicators of Neuronetics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -6.6 M | -6.9 M | |
| Interest Income | 4.2 M | 3.3 M | |
| Operating Income | -31.1 M | -32.7 M | |
| Net Loss | -39.4 M | -41.3 M | |
| Income Before Tax | -39.4 M | -41.3 M | |
| Total Other Income Expense Net | -8.3 M | -7.8 M | |
| Net Loss | -33.4 M | -35.1 M | |
| Net Loss | -39.4 M | -41.3 M | |
| Income Tax Expense | -12.6 K | -12 K | |
| Non Operating Income Net Other | 2.5 M | 2.7 M | |
| Change To Netincome | 10.1 M | 10.6 M | |
| Net Loss | (1.24) | (1.30) | |
| Income Quality | 0.64 | 0.70 | |
| Net Income Per E B T | 1.15 | 1.10 |
Neuronetics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Neuronetics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Neuronetics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Neuronetics' important profitability drivers and their relationship over time.
Neuronetics Earnings Estimation Breakdown
The calculation of Neuronetics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Neuronetics is estimated to be -0.13 with the future projection ranging from a low of -0.15 to a high of -0.11. Please be aware that this consensus of annual earnings estimates for Neuronetics is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.15 Lowest | Expected EPS | -0.11 Highest |
Neuronetics Earnings Projection Consensus
Suppose the current estimates of Neuronetics' value are higher than the current market price of the Neuronetics stock. In this case, investors may conclude that Neuronetics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Neuronetics' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 3 | 63.91% | 0.0 | -0.13 | -0.83 |
Neuronetics Earnings per Share Projection vs Actual
Actual Earning per Share of Neuronetics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Neuronetics predict the company's earnings will be in the future. The higher the earnings per share of Neuronetics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Neuronetics Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Neuronetics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Neuronetics should always be considered in relation to other companies to make a more educated investment decision.Neuronetics Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Neuronetics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-04 | 2025-09-30 | -0.13 | -0.13 | 0.0 | 0 | ||
2025-08-05 | 2025-06-30 | -0.08 | -0.15 | -0.07 | 87 | ||
2025-05-05 | 2025-03-31 | -0.1167 | -0.2062 | -0.0895 | 76 | ||
2025-03-04 | 2024-12-31 | -0.24 | -0.33 | -0.09 | 37 | ||
2024-11-05 | 2024-09-30 | -0.23 | -0.4408 | -0.2108 | 91 | ||
2024-08-12 | 2024-06-30 | -0.27 | -0.33 | -0.06 | 22 | ||
2024-05-07 | 2024-03-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2024-03-05 | 2023-12-31 | -0.26 | -0.19 | 0.07 | 26 | ||
2023-11-07 | 2023-09-30 | -0.31 | -0.33 | -0.02 | 6 | ||
2023-08-08 | 2023-06-30 | -0.35 | -0.17 | 0.18 | 51 | ||
2023-05-09 | 2023-03-31 | -0.39 | -0.38 | 0.01 | 2 | ||
2023-03-07 | 2022-12-31 | -0.38 | -0.3 | 0.08 | 21 | ||
2022-11-08 | 2022-09-30 | -0.42 | -0.28 | 0.14 | 33 | ||
2022-08-02 | 2022-06-30 | -0.41 | -0.39 | 0.02 | 4 | ||
2022-05-12 | 2022-03-31 | -0.4 | -0.41 | -0.01 | 2 | ||
2022-03-08 | 2021-12-31 | -0.32 | -0.29 | 0.03 | 9 | ||
2021-11-09 | 2021-09-30 | -0.3 | -0.31 | -0.01 | 3 | ||
2021-08-03 | 2021-06-30 | -0.24 | -0.29 | -0.05 | 20 | ||
2021-05-04 | 2021-03-31 | -0.31 | -0.31 | 0.0 | 0 | ||
2021-03-02 | 2020-12-31 | -0.24 | -0.19 | 0.05 | 20 | ||
2020-11-02 | 2020-09-30 | -0.28 | -0.18 | 0.1 | 35 | ||
2020-08-04 | 2020-06-30 | -0.51 | -0.41 | 0.1 | 19 | ||
2020-05-05 | 2020-03-31 | -0.5 | -0.63 | -0.13 | 26 | ||
2020-03-03 | 2019-12-31 | -0.44 | -0.41 | 0.03 | 6 | ||
2019-11-05 | 2019-09-30 | -0.43 | -0.37 | 0.06 | 13 | ||
2019-08-06 | 2019-06-30 | -0.41 | -0.39 | 0.02 | 4 | ||
2019-05-07 | 2019-03-31 | -0.4 | -0.42 | -0.02 | 5 | ||
2019-03-05 | 2018-12-31 | -0.37 | -0.35 | 0.02 | 5 | ||
2018-11-06 | 2018-09-30 | -0.62 | -0.29 | 0.33 | 53 | ||
2018-08-14 | 2018-06-30 | -0.84 | -30.6 | -29.76 | 3542 | ||
2018-06-29 | 2018-03-31 | 0 | 0.02 | 0.02 | 0 |
Use Neuronetics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Neuronetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuronetics will appreciate offsetting losses from the drop in the long position's value.Neuronetics Pair Trading
Neuronetics Pair Trading Analysis
The ability to find closely correlated positions to Neuronetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Neuronetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Neuronetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Neuronetics to buy it.
The correlation of Neuronetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neuronetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neuronetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Neuronetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Neuronetics position
In addition to having Neuronetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marijuana Thematic Idea Now
Marijuana
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
To fully project Neuronetics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Neuronetics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Neuronetics' income statement, its balance sheet, and the statement of cash flows.